EUSA Pharma Revenue and Competitors
Estimated Revenue & Valuation
- EUSA Pharma's estimated annual revenue is currently $45.7M per year.
- EUSA Pharma's estimated revenue per employee is $251,250
- EUSA Pharma's total funding is $54.2M.
Employee Data
- EUSA Pharma has 182 Employees.
- EUSA Pharma grew their employee count by -9% last year.
EUSA Pharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
2 | Head Franchise Oncology Germany | Reveal Email/Phone |
3 | Head Franchise, Oncology, UK & Ireland | Reveal Email/Phone |
4 | Head Global Regulatory Affairs Oncology | Reveal Email/Phone |
5 | Associate Medical Director D-A-CH, Oncology/Rare Diseases | Reveal Email/Phone |
6 | Regional Business Director | Reveal Email/Phone |
7 | Regional Business Director | Reveal Email/Phone |
8 | Legal Director | Reveal Email/Phone |
9 | Global Director Market Access and HEOR | Reveal Email/Phone |
10 | Oncology Portfolio Management Director | Reveal Email/Phone |
EUSA Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2860M | 3403 | 8% | $2B | $8.9B |
What Is EUSA Pharma?
EUSA Pharma is a rapidly growing specialty pharmaceutical company. We are passionate and committed to making our products globally available to enable patients to live and embrace life. Headquartered in the UK, we supply medicines and medical devices across Europe and the US through our direct sales force, and worldwide through a network of partners in more than 60 countries. We pride ourselves on living our values in everything we do - we respect, we care, we adapt, we have ambition and we deliver.
keywords:N/A
$54.2M
Total Funding
182
Number of Employees
$45.7M
Revenue (est)
-9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
EUSA Pharma News
Key players 3M Healthcare, GSK, Pfizer, Colgate-Palmolive, Norgine, Sobi, Bausch Health, EUSA Pharma, Camurus, Clinigen Group,...
Disclosures: Dr Goodman disclosed consulting for EUSA Pharma and Seagen. His coauthors also declared affiliations with biotech,...